CoChat

Plasma metabolite profile for primary open-angle glaucoma in three US cohorts and the UK Biobank

Zeleznik, Oana A., Kang, Jae H., Lasky-Su, Jessica, Eliassen, A. Heather, Frueh, Lisa, Clish, Clary B., Rosner, Bernard A., Elze, Tobias, Hysi, Pirro, Khawaja, Anthony, Wiggs, Janey L., Pasquale, Louis R., UK Biobank Eye and Vision Consortium · 2023 · Nature Communications
Cited by 66

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

Glaucoma is a progressive optic neuropathy and a leading cause of irreversible blindness worldwide. Primary open-angle glaucoma is the most common form, and yet the etiology of this multifactorial disease is poorly understood. We aimed to identify plasma metabolites associated with the risk of developing POAG in a case-control study (599 cases and 599 matched controls) nested within the Nurses’ Health Studies, and Health Professionals’ Follow-Up Study. Plasma metabolites were measured with LC-MS/MS at the Broad Institute (Cambridge, MA, USA); 369 metabolites from 18 metabolite classes passed quality control analyses. For comparison, in a cross-sectional study in the UK Biobank, 168 metabolites were measured in plasma samples from 2,238 prevalent glaucoma cases and 44,723 controls using NMR spectroscopy (Nightingale, Finland; version 2020). Here we show higher levels of diglycerides and triglycerides are adversely associated with glaucoma in all four cohorts, suggesting that they play an important role in glaucoma pathogenesis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-023-38466-w

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Research works printed but not linked: 83

  1. Quigley, H. A. Number of people with glaucoma worldwide. Br. J. Ophthalmol. 80, 389–393 (1996). · DOI · Paper page
  2. Gharahkhani, P. et al. Genome-wide meta-analysis identifies 127 open-angle glaucoma loci with consistent effect across ancestries. Nat. Commun. 12, 1258 (2021). · DOI · Paper page
  3. Goodacre, R., Vaidyanathan, S., Dunn, W. B., Harrigan, G. G. & Kell, D. B. Metabolomics by numbers: acquiring and understanding global metabolite data. Trends Biotechnol. 22, 245–252 (2004). · DOI · Paper page
  4. Roberts, L. D., Souza, A. L., Gerszten, R. E. & Clish, C. B. Targeted metabolomics. Curr. Protoc. Mol. Biol. Chapter 30 Unit 30.2.1–24 (2012). · DOI · Paper page
  5. Wang, Y., Hou, X. W., Liang, G. & Pan, C. W. Metabolomics in glaucoma: a systematic review. Investig. Ophthalmol. Vis. Sci. 62, 9 (2021). · DOI
  6. Gong, H. et al. Gut microbiota compositional profile and serum metabolic phenotype in patients with primary open-angle glaucoma. Exp. Eye Res. 191, 107921 (2020). · DOI
  7. Javadiyan, S. et al. Elevation of serum asymmetrical and symmetrical dimethylarginine in patients with advanced glaucoma. Investig. Ophthalmol. Vis. Sci. 53, 1923–1927 (2012). · DOI
  8. Umeno, A. et al. Comprehensive measurements of hydroxylinoleate and hydroxyarachidonate isomers in blood samples from primary open-angle glaucoma patients and controls. Sci. Rep. 9, 1–11 (2019). · DOI
  9. Kouassi Nzoughet, J. et al. A data mining metabolomics exploration of glaucoma. Metabolites 10, 49 (2020). · DOI
  10. Leruez, S. et al. A metabolomics profiling of glaucoma points to mitochondrial dysfunction, senescence, and polyamines deficiency. Investig. Ophthalmol. Vis. Sci. 59, 4355–4361 (2018). · DOI
  11. Burgess, L. G. et al. Metabolome-wide association study of primary open angle glaucoma. Investig. Ophthalmol. Vis. Sci. 56, 5020–5028 (2015). · DOI
  12. Cabrerizo, J., Urcola, J. A. & Vecino, E. Changes in the lipidomic profile of aqueous humor in open-angle glaucoma. J. Glaucoma 26, 349–355 (2017). · DOI
  13. Myer, C. et al. Differentiation of soluble aqueous humor metabolites in primary open-angle glaucoma and controls. Exp. Eye Res. 194, 108024 (2020). · DOI
  14. Buisset, A. et al. Metabolomic profiling of aqueous humor in glaucoma points to taurine and spermine deficiency: Findings from the Eye-D study. J. Proteome Res. 18, 1307–1315 (2019). · doi:10.1021/acs.jproteome.8b00915
  15. Pan, C.-W. et al. Differential metabolic markers associated with primary open-angle glaucoma and cataract in human aqueous humor. BMC Ophthalmol. 20, 1–8 (2020). · DOI
  16. Rossi, C. et al. Multi-omics approach for studying tears in treatment-naïve glaucoma patients. Int. J. Mol. Sci. 20, 4029 (2019). · DOI
  17. Boucard, C. C., Hoogduin, J. M., van der Grond, J. & Cornelissen, F. W. Occipital proton magnetic resonance spectroscopy (1H-MRS) reveals normal metabolite concentrations in retinal visual field defects. PLoS One 2, e222 (2007). · DOI
  18. Khanna, R. K. et al. Metabolomics and lipidomics approaches in human tears: a systematic review. Surv. Ophthalmol. 67, 1229–1243 (2022). · DOI
  19. Breda, J. B. et al. Metabolomic profiling of aqueous humor from glaucoma patients—the metabolomics in surgical ophthalmological patients (MISO) study. Exp. Eye Res. 201, 108268 (2020). · DOI
  20. Tang, Y. et al. Metabolomic profiling of aqueous humor and plasma in primary open-angle glaucoma patients points towards novel diagnostic and therapeutic strategy. Front. Pharmacol. 12, 621146 (2021). · DOI
  21. Kang, J. W., Park, B. & Cho, B. J. Comparison of risk factors for initial central scotoma versus initial peripheral scotoma in normal-tension glaucoma. Korean J. Ophthalmol. 29, 102–108 (2015). · doi:10.3341/kjo.2015.29.2.102
  22. Kim, J. M., Kyung, H., Shim, S. H., Azarbod, P. & Caprioli, J. Location of Initial Visual Field Defects in Glaucoma and Their Modes of Deterioration. Investig. Ophthalmol. Vis. Sci. 56, 7956–7962 (2015). · doi:10.1167/iovs.15-17297
  23. Park, S. C. et al. Initial parafoveal versus peripheral scotomas in glaucoma: risk factors and visual field characteristics. Ophthalmology 118, 1782–1789 (2011). · DOI
  24. Stegemann, C. et al. Lipidomics profiling and risk of cardiovascular disease in the prospective population-based Bruneck study. Circulation 129, 1821–1831 (2014). · DOI · Paper page
  25. Umeno, A. et al. Comprehensive measurements of hydroxylinoleate and hydroxyarachidonate isomers in blood samples from primary open-angle glaucoma patients and controls. Sci. Rep. 9, 2171 (2019). · DOI
  26. Rossi, C. et al. Multi-omics approach for studying tears in treatment-naive glaucoma patients. Int. J. Mol. Sci. 20, 4029 (2019). · DOI
  27. Chen, Y. Y. et al. Patients with primary open-angle glaucoma may develop ischemic heart disease more often than those without glaucoma: an 11-year population-based cohort study. PLoS One 11, e0163210 (2016). · DOI
  28. Newman-Casey, P. A., Talwar, N., Nan, B., Musch, D. C. & Stein, J. D. The relationship between components of metabolic syndrome and open-angle glaucoma. Ophthalmology 118, 1318–1326 (2011). · DOI · Paper page
  29. Xu, M. et al. Plasma lipid levels and risk of primary open-angle glaucoma: a genetic study using Mendelian randomization. BMC Ophthalmol. 20, 390 (2020). · DOI
  30. Wang, S. & Bao, X. Hyperlipidemia, blood lipid level, and the risk of glaucoma: a meta-analysis. Invest Ophthalmol. Vis. Sci. 60, 1028–1043 (2019). · DOI
  31. Pertl, L. et al. Triglycerides and open angle glaucoma—a meta-analysis with meta-regression. Sci. Rep. 7, 7829 (2017). · DOI
  32. Rasoulinejad, S. A. et al. The association between primary open angle glaucoma and clustered components of metabolic syndrome. Open Ophthalmol. J. 9, 149–155 (2015). · DOI
  33. Hamard, P., Hamard, H., Dufaux, J. & Quesnot, S. Optic nerve head blood flow using a laser Doppler velocimeter and haemorheology in primary open-angle glaucoma and normal pressure glaucoma. Br. J. Ophthalmol. 78, 449–453 (1994). · doi:10.1136/bjo.78.6.449
  34. Shoji, M. K. et al. Paired optic nerve microvasculature and nailfold capillary measurements in primary open-angle glaucoma. Transl. Vis. Sci. Technol. 10, 13–13 (2021). · doi:10.1167/tvst.10.7.13
  35. Anchisi, L., Dessi, S., Pani, A. & Mandas, A. Cholesterol homeostasis: a key to prevent or slow down neurodegeneration. Front. Physiol. 3, 486 (2012).
  36. Llano, D. A. & Devanarayan, V., Alzheimer’s Disease Neuroimaging, I. Serum phosphatidylethanolamine and lysophosphatidylethanolamine levels differentiate Alzheimer’s disease from controls and predict progression from mild cognitive impairment. J. Alzheimer’s Dis. 80, 311–319 (2021). · DOI
  37. Wood, P. L. et al. Targeted lipidomics distinguishes patient subgroups in mild cognitive impairment (MCI) and late-onset Alzheimer’s disease (LOAD). BBA Clin. 5, 25–28 (2016). · DOI · Paper page
  38. Meikle, P. J. et al. Plasma lipid profiling shows similar associations with prediabetes and type 2 diabetes. PLoS One 8, e74341 (2013). · DOI · Paper page
  39. Mejia, E. M. & Hatch, G. M. Mitochondrial phospholipids: role in mitochondrial function. J. Bioenerg. Biomembr. 48, 99–112 (2016). · DOI · Paper page
  40. Leruez, S. et al. A plasma metabolomic signature of the exfoliation syndrome involves amino acids, acylcarnitines, and polyamines. Investig. Ophthalmol. Vis. Sci. 59, 1025–1032 (2018). · DOI
  41. Ho, L. T. Y. et al. Role of the autotaxin-lysophosphatidic acid axis in glaucoma, aqueous humor drainage and fibrogenic activity. Biochim. Biophys. Acta Mol. Basis Dis. 1866, 165560 (2020). · DOI
  42. Honjo, M. et al. Autotaxin-lysophosphatidic acid pathway in intraocular pressure regulation and glaucoma subtypes. Investig. Ophthalmol. Vis. Sci. 59, 693–701 (2018). · DOI
  43. Milbeck, S. M. & Bhattacharya, S. K. Alteration in lysophospholipids and converting enzymes in glaucomatous optic nerves. Investig. Ophthalmol. Vis. Sci. 61, 60 (2020). · DOI
  44. Edwards, G., Aribindi, K., Guerra, Y., Lee, R. K. & Bhattacharya, S. K. Phospholipid profiles of control and glaucomatous human aqueous humor. Biochimie 101, 232–247 (2014). · DOI
  45. Aribindi, K., Guerra, Y., Lee, R. K. & Bhattacharya, S. K. Comparative phospholipid profiles of control and glaucomatous human trabecular meshwork. Investig. Ophthalmol. Vis. Sci. 54, 3037–3044 (2013). · DOI
  46. Aljohani, A. J. et al. Human trabecular meshwork sphingolipid and ceramide profiles and potential latent fungal commensalism. Investig. Ophthalmol. Vis. Sci. 55, 3413–3422 (2014). · DOI
  47. Aljohani, A. J., Munguba, G. C., Guerra, Y., Lee, R. K. & Bhattacharya, S. K. Sphingolipids and ceramides in human aqueous humor. Mol. Vis. 19, 1966 (2013).
  48. Chauhan, M. Z., Valencia, A.-K., Piqueras, M. C., Enriquez-Algeciras, M. & Bhattacharya, S. K. Optic nerve lipidomics reveal impaired glucosylsphingosine lipids pathway in glaucoma. Investig. Ophthalmol. Vis. Sci. 60, 1789–1798 (2019). · DOI
  49. Kamel, K., Farrell, M. & O’Brien, C. Mitochondrial dysfunction in ocular disease: focus on glaucoma. Mitochondrion 35, 44–53 (2017). · DOI
  50. Liu, H., Mercieca, K. & Prokosch, V. Mitochondrial markers in aging and primary open-angle glaucoma. J. Glaucoma 29, 295–303 (2020). · DOI
  51. Kong, G. Y., Van Bergen, N. J., Trounce, I. A. & Crowston, J. G. Mitochondrial dysfunction and glaucoma. J. Glaucoma 18, 93–100 (2009). · DOI · Paper page
  52. Izzotti, A., Bagnis, A. & Sacca, S. C. The role of oxidative stress in glaucoma. Mutat. Res. 612, 105–114 (2006). · DOI · Paper page
  53. Benoist d’Azy, C., Pereira, B., Chiambaretta, F. & Dutheil, F. Oxidative and anti-oxidative stress markers in chronic glaucoma: a systematic review and meta-analysis. PLoS One 11, e0166915 (2016). · DOI · Paper page
  54. Gonzalez-Granda, A., Damms-Machado, A., Basrai, M. & Bischoff, S. C. Changes in plasma acylcarnitine and lysophosphatidylcholine levels following a high-fructose diet: a targeted metabolomics study in healthy women. Nutrients 10, 1254 (2018). · DOI
  55. Calandrella, N., De Seta, C., Scarsella, G. & Risuleo, G. Carnitine reduces the lipoperoxidative damage of the membrane and apoptosis after induction of cell stress in experimental glaucoma. Cell Death Dis. 1, e62 (2010). · DOI
  56. Zarnowski, T. et al. A ketogenic diet may offer neuroprotection in glaucoma and mitochondrial diseases of the optic nerve. Med Hypothesis Discov. Innov. Ophthalmol. 1, 45–49 (2012).
  57. Bailey, J. N. et al. Hypothesis-independent pathway analysis implicates GABA and acetyl-CoA metabolism in primary open-angle glaucoma and normal-pressure glaucoma. Hum. Genet. 133, 1319–1330 (2014). · DOI
  58. Hanyuda, A. et al. Low-carbohydrate-diet scores and the risk of primary open-angle glaucoma: data from three US cohorts. Eye 34, 1465–1475 (2020). · DOI
  59. Khawaja, A. P. et al. Assessing the association of mitochondrial genetic variation with primary open-angle glaucoma using gene-set analyses. Investig. Ophthalmol. Vis. Sci. 57, 5046–5052 (2016). · DOI
  60. Zeleznik, O. A. et al. Circulating amino acids and amino acid-related metabolites and risk of breast cancer among predominantly premenopausal women. NPJ Breast cancer 7, 1–10 (2021). · DOI
  61. Zeleznik, O. A. et al. Circulating lysophosphatidylcholines, phosphatidylcholines, ceramides, and sphingomyelins and ovarian cancer risk: a 23-year prospective study. J. Natl Cancer Inst. 112, 628–636 (2020). · doi:10.1093/jnci/djz195
  62. Zeleznik, O. A. et al. A prospective analysis of circulating plasma metabolites associated with ovarian cancer risk. Cancer Res. 80, 1357–1367 (2020). · DOI
  63. Townsend, M. K. et al. Reproducibility of metabolomic profiles among men and women in 2 large cohort studies. Clin. Chem. 59, 1657–1667 (2013). · DOI · Paper page
  64. Zeleznik, O. A. et al. Intrapersonal stability of plasma metabolomic profiles over 10 years among women. Metabolites 12, 372 (2022). · DOI
  65. Kang, J. H., Loomis, S. J., Rosner, B. A., Wiggs, J. L. & Pasquale, L. R. Comparison of risk factor profiles for primary open-angle glaucoma subtypes defined by pattern of visual field loss: a prospective study. Investig. Ophthalmol. Vis. Sci. 56, 2439–2448 (2015). · DOI
  66. Kang, J. H., Willett, W. C., Rosner, B. A., Hankinson, S. E. & Pasquale, L. R. Prospective study of alcohol consumption and the risk of primary open-angle glaucoma. Ophthalmic Epidemiol. 14, 141–147 (2007). · DOI
  67. Bailey, J. N. et al. Genome-wide association analysis identifies TXNRD2, ATXN2 and FOXC1 as susceptibility loci for primary open-angle glaucoma. Nat. Genet. 48, 189–194 (2016). · DOI · Paper page
  68. Hysi, P. G. et al. Genome-wide analysis of multi-ancestry cohorts identifies new loci influencing intraocular pressure and susceptibility to glaucoma. Nat. Genet. 46, 1126–1130 (2014). · DOI · Paper page
  69. Wiggs, J. L. et al. The NEIGHBOR consortium primary open-angle glaucoma genome-wide association study: rationale, study design, and clinical variables. J. Glaucoma 22, 517–525 (2013). · DOI
  70. Wiggs, J. L. et al. Common variants near CAV1 and CAV2 are associated with primary open-angle glaucoma in Caucasians from the USA. Hum. Mol. Genet. 20, 4707–4713 (2011). · DOI · Paper page
  71. MacGregor, S. et al. Genome-wide association study of intraocular pressure uncovers new pathways to glaucoma. Nat. Genet. 50, 1067–1071 (2018). · DOI · Paper page
  72. Khawaja, A. P. et al. Genome-wide analyses identify 68 new loci associated with intraocular pressure and improve risk prediction for primary open-angle glaucoma. Nat. Genet. 50, 778–782 (2018). · DOI · Paper page
  73. Kim, J. et al. Intraocular pressure, glaucoma, and dietary caffeine consumption: a gene-diet interaction study from the UK Biobank. Ophthalmology 128, 866–876 (2021). · DOI
  74. Kim, J. et al. Statin use in relation to intraocular pressure, glaucoma, and ocular coherence tomography parameters in the UK Biobank. Investig. Ophthalmol. Vis. Sci. 63, 31 (2022). · DOI
  75. Han, X. et al. Associations of sleep apnoea with glaucoma and age-related macular degeneration: an analysis in the United Kingdom Biobank and the Canadian longitudinal study on aging. BMC Med 19, 104 (2021). · DOI
  76. Paynter, N.P. et al. Metabolic predictors of incident coronary heart disease in women. Circulation 137, 841–853 (2018) · DOI · Paper page
  77. O’Sullivan, J. F. et al. Dimethylguanidino valeric acid is a marker of liver fat and predicts diabetes. J. Clin. Invest 127, 4394–4402 (2017). · DOI
  78. Mascanfroni, I. D. et al. Metabolic control of type 1 regulatory T cell differentiation by AHR and HIF1-alpha. Nat. Med. 21, 638–646 (2015). · DOI · Paper page
  79. Julkunen, H., Cichonska, A., Slagboom, P. E. & Wurtz, P., Nightingale Health, U.K.B.I. Metabolic biomarker profiling for identification of susceptibility to severe pneumonia and COVID-19 in the general population. Elife 10, e63033 (2021). · DOI · Paper page
  80. Soininen, P., Kangas, A. J., Wurtz, P., Suna, T. & Ala-Korpela, M. Quantitative serum nuclear magnetic resonance metabolomics in cardiovascular epidemiology and genetics. Circ. Cardiovasc. Genet. 8, 192–206 (2015). · DOI · Paper page
  81. Mihaleva, V. V. et al. Automated quantum mechanical total line shape fitting model for quantitative NMR-based profiling of human serum metabolites. Anal. Bioanal. Chem. 406, 3091–3102 (2014). · DOI
  82. Kang, J. H. et al. Association of dietary nitrate intake with primary open-angle glaucoma: a prospective analysis from the nurses’ health study and health professionals follow-up study. JAMA Ophthalmol. 134, 294–303 (2016). · DOI
  83. Kang, J. H., Willett, W. C., Rosner, B. A., Hankinson, S. E. & Pasquale, L. R. Caffeine consumption and the risk of primary open-angle glaucoma: a prospective cohort study. Investig. Ophthalmol. Vis. Sci. 49, 1924–1931 (2008). · DOI

Metadata

Authors
Zeleznik, O. A., Kang, J. H., Lasky-Su, J., Eliassen, A. H., Frueh, L., Clish, C. B., Rosner, B. A., Elze, T., Hysi, P., Khawaja, A., Wiggs, J. L., Pasquale, L. R., & UK Biobank Eye and Vision Consortium
Venue
Nature Communications
Published
2023-05-19
Volume
14
Issue
1
ISSN
2041-1723
Cited by
66
References
9
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Plasma metabolite profile for primary open-angle glaucoma in three US cohorts and the UK Biobank. https://app.cochat.ai/papers/10.1038/s41467-023-38466-w
The paper
Zeleznik, O. A., Kang, J. H., Lasky-Su, J., Eliassen, A. H., Frueh, L., Clish, C. B., Rosner, B. A., Elze, T., Hysi, P., Khawaja, A., Wiggs, J. L., Pasquale, L. R., & UK Biobank Eye and Vision Consortium. (2023). Plasma metabolite profile for primary open-angle glaucoma in three US cohorts and the UK Biobank. Nature Communications. https://doi.org/10.1038/s41467-023-38466-w

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.